PathogenDx inks partnership with Nationwide Laboratory Services to deploy ultra─rapid molecular pathology for rapid strain identification – Pharma News

PathogenDx, Inc., the Arizona based technology company which provides a DNA─based pathogen testing platform for the cannabis, hemp, agriculture and food safety industries, announced that they have entered

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Scientists find new therapy administered after TBI prevents brain damage – Pharma News

The University of Texas Health Science Center at San Antonio researchers reported that an experimental treatment given to mice after a traumatic brain injury (TBI) reduced damage almost to the levels of mice

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

HCG─ Lumos to spur med─tech start─ups eco─system with Anthill funding between US$ 20,000 to US$ 1 million – Pharma News

HealthCare Global Enterprises (HCG), the largest provider of cancer care in India which devised the Lumos Health Market Access Programme, is focused on scaling technology start─ups in healthcare and life sciences

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Argenx begins phase 1 trial of Efgartigimod with Enhanze drug delivery technology – Pharma News

Halozyme Therapeutics, a biotechnology company developing novel oncology and drug─delivery therapies, announced that argenx has dosed the first subject in a phase 1 clinical trial evaluating the safety,

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Astellas, Frequency ink licensing pact to develop regenerative therapeutic candidate, FX─322 for hearing loss – Pharma News

Astellas Pharma and Frequency Therapeutics have entered into an exclusive license agreement to develop and commercialize Frequency’s regenerative therapeutic candidate, FX─322, for the treatment of

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

PureTech acquires new clinical─stage programme LYT─100 to treat lymphedema – Pharma News

PureTech Health, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain─Immune─Gut (BIG) axis, announced it has acquired and plans to develop a clinical─stage product

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Paragon 28 adds Grappler Interference Screw System to its flatfoot platform – Pharma News

Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Anixa Biosciences establishes strategic alliance & licensing pact with Cleveland Clinic for an innovative breast cancer vaccine technology – Pharma News

Anixa Biosciences, Inc., a biotechnology company focused on harnessing the body’s immune system to fight cancer, has established a strategic alliance and license agreement with Cleveland Clinic for an innovative

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Eisai receives Chinese approval for Halaven to treat locally advanced/metastatic breast cancer – Pharma News

Eisai Co, Ltd announced that the China National Medical Products Administration (NMPA) has approved its in─house developed anticancer agent Halaven (eribulin mesylate) for use in the treatment of patients with

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

CAHOTECH 2019 to be held in Chennai on 27th & 28th September – Pharma News

CAHOTECH 2019 is now in Chennai, the city with the perfect mix of a robust healthcare system and a thriving IT infrastructure, on 27th & 28th September 2019. The event will show the strength of being one of the

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

US FDA accepts Allergan’s NDA for Bimatoprost SR for patients with open─angle glaucoma/ocular hypertension – Pharma News

Allergan plc, a leading global pharmaceutical company with more than 70 years of heritage in eye care, announced that the US FDA has accepted the company’s New Drug Application (NDA) for Bimatoprost Sustained─

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Janssen Korea, J&J Innovation launch Seoul Innovation QuickFire Challenge in Smart Healthcare in collaboration with Seoul Metropolitan Government & KHIDI – Pharma News

Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, a global network of open innovation ecosystems, announced the launch of the Seoul Innovation QuickFire Challenge in Smart Healthcare in

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Merck’s Recarbrio gets US FDA nod to treat adults patients with cUTI & cIAI where limited/no alternative treatment options are available – Pharma News

Merck,a leading global biopharmaceutical company known as MSD outside of the United States and Canada, announced that the US Food and Drug Administration (FDA) has approved Recarbrio (imipenem,

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Union Cabinet approves Rs.330 crore loan to help three PSU pharma cos – Pharma News

The Union Cabinet has approved loans worth Rs.330.35 crore for three public sector pharma companies for meeting the employees’ liabilities. The three PSU companies are Indian Drugs & Pharmaceuticals Limited

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

NIH funded study shows persistent HIV in central nervous system linked to cognitive impairment – Pharma News

Many people with HIV on antiretroviral therapy (ART) have viral genetic material in the cells of their cerebrospinal fluid (CSF), and these individuals are more likely to experience memory and concentration

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

National Conference on Drug innovation and Discoveries to be held at Palamuru University from July19─20 in Mahbubnagar in TS – Pharma News

With an aim to promote innovative techniques in the drug discoveries among the pharmaceutical students and researchers, the University College of Pharmaceuticals at Palamuru University is organisation a two

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

NextGen Healthcare partners with Appriss Health to combat substance use disorder – Pharma News

NextGen Healthcare, Inc, the leading provider of ambulatory─focused technology solutions, announced that it has integrated Appriss Health prescription monitoring and tracking analytics into NextGen Office, the

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Axial Bio begins patient dosing in phase 1b/2a trial of AB─2004 to treat GI dysfunction and associated behavioural symptoms of ASD – Pharma News

Axial Biotherapeutics, a clinical stage biotechnology company, announced the dosing of the first patient in its phase 1b/2a clinical trial of AB─2004. In animal models, AB─2004 has demonstrated the ability to

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Abcam acquires EdiGene’s Knock─out cell lines and lysates portfolio – Pharma News

Abcam plc, a global innovator in life science reagents and tools, announced the acquisition of the entire live cell line and lysates portfolio of EdiGene Inc, a leading company focused on developing genome

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Kite to build 67,000─square─foot new viral vector facility in Oceanside – Pharma News

Kite, a Gilead biopharmaceutical company, announced plans for a new 67,000─square─foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a critical starting material

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Mallinckrodt to discontinue phase 2B trial of Acthar gel to treat amyotrophic lateral sclerosis – Pharma News

Mallinckrodt, a leading global specialty biopharmaceutical company, announced that it is permanently discontinuing its phase 2B study designed to assess the efficacy and safety of Acthar Gel (repository corticotropin injection)

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Inovio to cut selected R&D programmes, discontinues phase 1/2 study in advanced bladder cancer & reduce workforce by 28% – Pharma News

Inovio Pharmaceuticals, Inc announced that it has sharpened its corporate strategy to focus on the commercial development of its late─stage HPV assets and reallocate capital to develop fast─to─market product candidates.

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

Astellas & Seattle Genetics seek US FDA approval for enfortumab vedotin for patients with locally advanced/metastatic urothelial cancer – Pharma News

Astellas Pharma, a company dedicated to improving the health of people and Seattle Genetics, a global biotechnology company, announced submission of a Biologics License Application for accelerated approval to the US Food and Drug Administration

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…

VC funding in digital health hits US$ 5.1 billion in 1H 2019: Mercom Capital Group – Pharma News

Mercom Capital Group, llc, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the digital health (healthcare information technology) sector

Subscribe to Read more: http://eepurl.com/gc_zc1
OMEN Pharma News Receive Daily Updates Directly into your Mailbox and stay updated with all the major happenings in the Pharma Industry…